ストックスクリーナーアプリを入手
94.66
7.84%
-8.05
プレマーケット:
95.85
1.19
+1.26%
前日終値:
$102.71
開ける：
$92.608
24時間の取引高:
4.77M
Relative Volume:
2.09
時価総額：
$14.98B
収益：
$4.34B
当期純損益:
$-965.00M
株価収益率:
-15.59
EPS:
-6.07
ネットキャッシュフロー:
$869.00M
1週間 パフォーマンス:
-13.39%
1か月 パフォーマンス:
-3.56%
6か月 パフォーマンス:
-28.69%
1年 パフォーマンス:
-22.63%
1日の値動き範囲:
$92.19
$99.90
1週間の範囲:
$92.19
$111.00
52週間の値動き範囲:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
ILMN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
94.66 | 16.26B | 4.34B | -965.00M | 869.00M | -6.07 |
|
TMO
Thermo Fisher Scientific Inc
|
463.04 | 176.55B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.09 | 141.18B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
535.54 | 42.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.50 | 32.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.45 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 繰り返されました | Citigroup | Neutral |
| 2025-02-28 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-02-10 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-02-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-11-12 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-10-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-08-28 | アップグレード | Argus | Hold → Buy |
| 2024-08-16 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-08-14 | アップグレード | TD Cowen | Hold → Buy |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-01-16 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-01-04 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-12-11 | アップグレード | Citigroup | Sell → Neutral |
| 2023-11-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 開始されました | Bernstein | Underperform |
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-25 | ダウングレード | Argus | Buy → Hold |
| 2023-01-05 | 開始されました | Scotiabank | Sector Perform |
| 2022-12-12 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-04 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-07-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-01-18 | アップグレード | Stifel | Hold → Buy |
| 2022-01-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-01-07 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-19 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-03-31 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 開始されました | Barclays | Underweight |
| 2020-12-22 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-10-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | ダウングレード | Stifel | Buy → Hold |
| 2020-09-22 | ダウングレード | UBS | Buy → Neutral |
| 2020-09-21 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-09-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-08-07 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2020-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-04-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-04-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-10-25 | 開始されました | Guggenheim | Buy |
すべてを表示
Illumina Inc (ILMN) 最新ニュース
Multi-Omics Market to Surpass US$33.25 Billion by 2033, Driven - openPR.com
Illumina: The Stock Is Still Undervalued (NASDAQ:ILMN) - Seeking Alpha
Illumina Settles Allegations of Cyber Vulnerabilities in Genomic Sequencing for $9.8M - Claims Journal
What are Illumina Inc. company’s key revenue driversSuperior stock growth - jammulinksnews.com
What is Illumina Inc. company’s growth strategyGame-changing returns - jammulinksnews.com
What makes Illumina Inc. stock price move sharplyFree Trend-Following Techniques - jammulinksnews.com
Should I hold or sell Illumina Inc. stock in 2025Extraordinary market timing - jammulinksnews.com
Illumina, Inc.'s (NASDAQ:ILMN) Stock Is Going Strong: Have Financials A Role To Play? - simplywall.st
How does Illumina Inc. compare to its industry peersBuild a balanced portfolio for long-term success - jammulinksnews.com
How strong is Illumina Inc. company’s balance sheetInvest confidently with professional guidance - jammulinksnews.com
What are the technical indicators suggesting about Illumina Inc.Capitalize on market opportunities with confidence - jammulinksnews.com
Illumina CEO Bets on Pharma Partnerships for Genomics Revival - WebProNews
Pharma interest can plug NIH funding gap: Illumina CEO - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Q2 2025 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion - Benzinga
Illumina’s Q2 2025 Earnings and Strategic Moves - The Globe and Mail
Genomics Gear Firm Pays $9.8M to Settle False Cyber Claims - BankInfoSecurity
Illumina (ILMN) Q2 EPS Jumps 9% - Nasdaq
Illumina hit with $9.8M fine for unsecure sequencing equipment - BioWorld MedTech
Why Illumina (ILMN) Shares Are Falling Today - Yahoo Finance
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims - Cybersecurity Dive
Illumina Fined $9.8M for Cybersecurity Flaws in Genomic Tools Sold to U.S. Agencies - gbhackers.com
Illumina Q2 2025 revenue down 3% to USD 1.06B - Medical Buyer
Illumina Connected Insights Feature HighlightHeme Subtyping - Illumina
Illumina fined $9.8M for selling DNA sequencers with cybersecurity flaws to U.S. agenciesRegtechtimes - Regtechtimes
When is Illumina Inc. stock expected to show significant growthMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
Illumina: Q2 Earnings Snapshot - CTPost
Illumina Outpaces Wall Street Despite Sliding Revenue In Q2 - Finimize
Illumina, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ILMN) - Seeking Alpha
Illumina 2025 Q2 Earnings Remarkable Turnaround with 111.8% Net Income Improvement - AInvest
Illumina Beats Profit Forecasts Even As Sales Slip Slightly - Finimize
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
Illumina Q2 2025 slides: revenue declines 3% while margins expand, SomaLogic acquisition announced - Investing.com
Illumina: A 5.2 Rating Amid Challenges and Opportunities - The Globe and Mail
Earnings call transcript: Illumina beats Q2 2025 EPS forecast by 17.8% - Investing.com Nigeria
Illumina Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Illumina (NASDAQ:ILMN) Surprises With Q2 Sales - Yahoo Finance
Illumina reports a decline in revenue despite beating estimates - Seeking Alpha
Illumina earnings beat by $0.18, revenue topped estimates - Investing.com Canada
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 - PR Newswire
Biotech contractor settles for $9.8 million with DOJ over alleged cybersecurity lapses - The Record from Recorded Future News
Illumina, DOJ Reach $9.8 Million False Claims Act Settlement - Bloomberg Law News
Illumina agrees to $9.8 million settlement over cybersecurity vulnerabilities in genomic sequencing systems - MLex
Illumina Inc. Agrees to Pay $9.8M in Settlement Over Alleged Security - Hoodline
Illumina to Pay $9.8M to Resolve Cybersecurity Qui Tam Lawsuit Filed Under False Claims Act - USA Herald
What is the dividend policy of Illumina Inc. stockAdvanced Screener Guidance From AI Tools - jammulinksnews.com
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics - sharewise.com
What are analysts’ price targets for Illumina Inc. in the next 12 monthsLow Risk Watchlist That Work - jammulinksnews.com
Illumina Releases TSO 500 v2 Assay with Integrated HRD Detection and Reduced Sample Requirements - geneonline.com
Illumina To Pay $9.8M To Resolve Cybersecurity Qui Tam Case - Law360
Illumina Inc (ILMN) 財務データ
収益
当期純利益
現金流量
EPS
0.54%
2.95%
大文字化:
|
ボリューム (24 時間):